Physician profile
Antao Du
NPI 1396916037
$2,930.42
in general payments reported to CMS, 2019-2025
20 companies · $514 in 2025
The $514 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $317 · 2021: $665 · 2022: $412 · 2023: $249 · 2024: $533 · 2025: $514.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,295.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $824.67 | 2019-2025 | Qulipta, Ubrelvy |
| Pfizer INC. | $365.86 | 2023-2025 | |
| Biohaven Pharmaceuticals, INC. | $273.35 | 2020-2021 | |
| Allergan, INC. | $215.60 | 2020 | |
| Livanova USA, INC. | $197.69 | 2019-2025 | Vns Therapy Sentiva Model 1000 Generator |
| Sunovion Pharmaceuticals INC. | $158.93 | 2019-2020 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $131.54 | 2022 | |
| Amgen INC. | $125.00 | 2025 | Uplizna |
| Biogen, INC. | $99.62 | 2024-2025 | Leqembi, Skyclarys |
| Ucb, INC. | $98.79 | 2024-2025 | Fintepla, Briviact |
| Ge Healthcare | $96.93 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $71.50 | 2021 | |
| Upsher-Smith Laboratories LLC | $69.39 | 2021 | |
| Eisai INC. | $66.50 | 2024-2025 | |
| Lundbeck LLC | $41.70 | 2024-2025 | Vyepti |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $22.88 | 2024 | Nuedexta |
| Celgene Corporation | $19.32 | 2025 | Zeposia |
| Amneal Pharmaceuticals LLC | $18.31 | 2025 | Crexont |
| Genentech USA, INC. | $17.92 | 2019 | |
| Lilly USA, LLC | $14.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Antao Du listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.